Preservation of hypothalamic-pituitary-adrenal axis fast-feedback responses in depression

Acta Psychiatrica Scandinavica

Volumn 94, Issue 6, 1996, Pages 449-453

  Cooney, J M ^a   Dinan, T G ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

cortisol; depression; negative feedback

Indexed keywords

HYDROCORTISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; HYPERACTIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PRIORITY JOURNAL; PROVOCATION TEST;

EID: 0030447181     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1996.tb09889.x     Document Type: Article

References (44)

1. ORTH DN, KOVACS KJ, ROWEN DEBOLD C. The adrenal cortex. In: WILSON JD, FOSTER DW, ed. William's textbook of endocrinology. Philadelphia: W.B. Saunders, 1992: 486-621.
2. GIBBONS JL, MCHUGH PR. Plasma cortisol in depressive illness. Psychiatry Res 1963: 1: 162-171.
3. SACHAR EJ, HELLMAN L, ROFFWARG HP, HALPERN FS, FUKUSHIMA DK, GALLAGHER TF. Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Arch Gen Psychiatry 1973: 28: 19-24.
4. CARROLL BJ, CURTIS GC, DAVIES BM, MENDELS J, SUGERMAN AA. Urinary free cortisol excretion in depression. Psychol Med 1976: 6: 43-50.
5. HALBREICH U, ASNIS GM, SHINDLEDECKER R, ZUMOFF B, NATHAN RS. Cortisol secretion in endogenous depression. I. Basal plasma levels. Arch Gen Psychiatry 1985: 42: 904-908.
6. AMSTERDAM JD, MARINELLI DL, ARGER P, WINOKUR A. Assessment of adrenal gland volume by computed tomography in depressed patients and healthy volunteers: a pilot study. Psychiatry Res 1987: 21: 189-197.
7. NEMEROFF CB, KRISHNAN KR, REED D, LEDER R, BEAM C, DUNNICK NR. Adrenal gland enlargement in major depression. A computed tomographic study. Arch Gen Psychiatry 1992: 49: 384-387.
8. RUBIN RT, PHILLIPS JJ, SADOW TF, MCCRACKEN JT. Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment. Arch Gen Psychiatry 1995: 52: 213-218.
9. JEFFCOATE WJ, SILVERSTONE JT, EDWARDS CR, BESSER GM. Psychiatric manifestations of Cushing's syndrome: response to lowering of plasma cortisol. Q J Med 1979: 48: 465-472.
10. WOLKOWITZ OM, REUS VI, MANFREDI F, INGBAR J, BRIZENDINE L, WEINGARTNER H. Ketoconazole administration in hypercortisolaemic depression. Am J Psychiatry 1993: 150: 810-812.
11. THAKORE JH, DINAN TG. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression. Biol Psychiatry 1995: 37: 364-368.
12. GORMLEY GJ, LOWY MT, REDER AT, HOSPELHORN VD, ANTEL JP, MELTZER HY. Glucocorticoid receptors in depression: relationship to the dexamethasone suppression test. Am J Psychiatry 1985: 142: 1278-1284.
13. WHALLEY LJ, BORTHWICK N, COPOLOV D, DICK H, CHRISTIE JE, FINK G. Glucocorticoid receptors and depression. Br Med J 1986: 292: 859-861.
14. LOWY MT, REDER AT, ANTEL JP, MELTZER HY. Glucocorticoid resistance in depression: the dexamethasone suppression test and lymphocyte sensitivity to dexamethasone. Am J Psychiatry 1984: 141: 1365-1370.
15. MURPHY BEP. Steroids and depression. J Steroid Biochem Mol Biol 1991: 38: 537-559.
16. LOWY MT, REDER AT, GORMLEY GJ, MELTZER HY. Comparison of in vivo and in vitro glucocorticoid sensitivity in depression: relationship to the dexamethasone suppression test. Biol Psychiatry 1988: 24: 619-630.
17. BRADBURY MJ, AKANA SF, DALLMAN MF. Roles of type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation. Endocrinology 1994: 134: 1286-1296.
18. JONES MT, GILHAM B. Factors involved in the regulation of adrenocorticotropic hormone/beta-lipotropic hormone. Physiol Rev 1988: 68: 743-817.
19. CARROLL BJ. The dexamethasone suppression test for melancholia. Br J Psychiatry 1982: 140: 292-304.
20. SPENCER RL, YOUNG EA, CHOO PH, MCEWEN BS. Adrenal steroid type I and type II receptor binding: estimated in vivo receptor number, occupancy and activation with varying levels of steroid. Brain Res 1990: 514: 37-48.
21. MILLER AH, SPENCER RL, PULERA M, KANG S, MCEWEN BS, STEIN M. Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone: implications for the dexamethasone suppression test. Biol Psychiatry 1992: 32: 850-869.
22. RUPPRECHT R, LESCH KP, MULLER U, BECK G, BECKMANN H, SCHULTE HM. Blunted adrenocorticotropin but normal beta-endorphin release after human corticotropin-releasing hormone administration in depression. J Clin Endocrinol Metab 1989: 69: 600-603.
23. YOUNG EA, HASKETT RF, MURPHY-WEINBERG V, WATSON SJ, AKIL H. Loss of glucocorticoid fast feedback in depression. Arch Gen Psychiatry 1991: 48: 693-699.
24. HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960: 23: 56-62.
25. DASH RJ, ENGLAND BC, REES MIDGELEY A JR, NISWENDER GD. A specific, nonchromatographic radioimmunoassay for human plasma cortisol. Steroids 1975: 26: 647-661.
26. RAFF H, FINDLING JW. A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome. Clin Chem 1989: 35: 596-600.
27. Statistical Graphics Corporation. Statgraphics version 7.0. Cambridge, MA: Manguistics Inc., 1993.
28. COONEY JM, DINAN TG. Type II (glucocorticoid) receptors mediate fast-feedback inhibition of the hypothalamic-pituitary-adrenal axis in man. Life Sci (in press).
29. BORN J, DITSCHUNEIT I, SCHREIBER M, DODT C, FEHM HL. Effects of age and gender on pituitary-adrenocortical responsiveness in humans. Eur J Endocrinol 1995: 132: 705-711.
30. BERTAGNA X, COSTE J, RAUX-DEMAY MC, LETRAIT M, STRAUCH G. The combined corticotropin-releasing hormone/lysine vasopressin test discloses a corticotroph phenotype. J Clin Endocrinol Metab 1994: 79: 390-394.
31. YOUNG EA, DAY R, SCHAFER M, WATSON SJ, AKIL H. Altered ratios of beta-endorphin: beta-lipotropin released from anterior lobe corticotropes with increased secretory drive. II. Repeated stress. J Neuroendocrinol 1993: 5: 121-126.
32. YOUNG EA, WATSON SJ, AKIL H. Pituitary regulation in endogenous depression. In: VAN REE JM, MATTYHSSESSE S, ed. Psychiatric disorders: neurotransmitters and neuropeptides. New York: Elsevier Science Publishing Co. Inc., 1986: 153-166.
33. STOKES PE, SIKES CR. The hypothalamic-pituitary-adrenocortical axis in major depression. Endocrinol Metab Clin N Am 1988: 17: 1-19.
34. POTTER WZ, MANJI HK. Catecholamines in depression: an update. Clin Chem 1994: 40: 279-287.
35. RUPPRECHT R, KORNHUBER J, WODARZ N et al. Disturbed glucocorticoid receptor autoregulation and corticotropin response to dexamethasone in depressives pretreated with metyrapone. Biol Psychiatry 1991: 29: 1099-1109.
36. YOUNG EA. Normal glucorticoid fast feedback following chronic 50% corticosterone pellet treatment. Psychoneuroendocrinology 1995: 20: 771-784.
37. UR E, DINAN TG, O'KEANE V et al. Effect of metyrapone on the pituitary-adrenal axis in depression: relation to dexamethasone suppressor status. Neuroendocrinology 1992: 56: 533-538.
38. YOUNG EA, HASKETT RF, GRUNHAUS L et al. Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients. Arch Gen Psychiatry 1994: 51: 701-707.
39. MURPHY BE, DHAR V, GHADIRIAN AM, CHOUINARD G, KELLER R. Response to steroid suppression in major depression resistant to antidepressant therapy. J Clin Psychopharmacology 1991: 11: 121-126.
40. KRAMLINGER KG, PETERSON GC, WATSON PK, LEONARD LL. Metyrapone for depression and delirium secondary to Cushing's syndrome. Psychosomatics 1985: 26: 67.
41. ARANA GW, FORBES RA. Dexamethasone for the treatment of depression: a preliminary report. J Clin Psychiatry 1991: 52: 304-306.
42. ARANA GW, SANTOS AB, LARAIA MT et al. Dexamethasone for the treatment of depression: a randomized, placebo-controlled, double-blind trial. Am J Psychiatry 1995: 152: 265-267.
43. MURPHY BE, FILIPINI D, GHADIRIAN AM. Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486. J Psychiatry Neurosci 1993: 18: 209-213.
44. HOLSBOER F, SPENGLER D, HEUSER I. The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog Brain Res 1992: 93: 385-417.